NCT00516893 · Interventional trial
Natalizumab High Titer Immunogenicity and Safety
Overall registry status Completed
Phase 2
Conditions Multiple Sclerosis
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory